AlphaMol Science

AlphaMol Science is a biotechnology company specializing in AI-driven drug discovery with a focus on G protein-coupled receptors (GPCRs). The company integrates advanced molecular dynamics simulations, artificial intelligence, and biophysical methods to accelerate the development of novel small molecule therapeutics for traditionally challenging targets. Their proprietary platform enables high-precision modeling of receptor signaling, facilitating the design of highly selective modulators for metabolic, neurological, and oncological indications. Founded by world-renowned experts in GPCR structural biology and computational chemistry, AlphaMol maintains research operations in both Shenzhen and Switzerland. The firm aims to bridge the gap between computational prediction and clinical success through its interdisciplinary approach to drug design.